Free Trial

Lumos Pharma (LUMO) SEC Filings & 10K Form

Lumos Pharma logo
$4.32 -0.01 (-0.23%)
(As of 11/20/2024 ET)

Recent Lumos Pharma SEC Filings

DateFilerForm TypeView
11/14/2024
8:04 AM
LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
Form SC 14D9
11/14/2024
7:22 AM
Double Point Ventures LLC (Filed by)
LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
Form SC TO-T
11/07/2024
2:12 PM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/25/2024
9:43 AM
LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
WELLS FARGO & COMPANY/MN (Filed by)
Form SCHEDULE 13G/A
10/23/2024
7:24 AM
LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
Form SC14D9C
10/23/2024
7:10 AM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
4:09 PM
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
McKew John C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
4:18 PM
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
McKew John C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
4:19 PM
Lawley Lori D (Reporting)
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2024
7:18 AM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
4:07 PM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
6:45 PM
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
Pitukcheewanont Pisit Duke (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
8:57 AM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2024
3:30 PM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form 10-K/A
04/18/2024
3:53 PM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2024
3:32 PM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form ARS
04/12/2024
4:27 PM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form DEFA14A
04/12/2024
4:01 PM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form DEF 14A
03/20/2024
3:27 PM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2024
3:44 PM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2024
3:48 PM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/09/2024
6:14 PM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
Form SC 13G/A
02/07/2024
4:22 PM
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
McKew John C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
8:57 AM
LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
WELLS FARGO & COMPANY/MN (Filed by)
Form SC 13G
02/05/2024
4:51 PM
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
POWERS BRADLEY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
4:52 PM
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
Schuchart Aaron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
4:53 PM
Lawley Lori D (Reporting)
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
6:03 PM
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
Pitukcheewanont Pisit Duke (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/29/2023
3:30 PM
Blackstone Holdings II L.P. (Filed by)
LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
Form SC 13D/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LUMO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners